Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Astellas Pharma Ltd
3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419583
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo@gb.astellas.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 13/04/2011
SPC Conotrane Cream

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   13-Dec-2010
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


In section 7 the address of the MAH, Astellas Pharma Ltd., has been updated following a move to new premises.  This entails the address changing from Lovett House, Lovett Road, Staines, TW18 3AZ, United Kingdom to 3rd Floor, Future House, The Glanty, Egham, Surrey, TW20 9AH, United Kingdom.

 

In section 10 the last revision date of the text has been revised to correspond with this move to new premises as detailed in Section 7.  This date is updated to 13th December 2010.
Updated on 31/01/2008 and displayed until 13/04/2011
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
Date of revision of text on the SPC:   01/2008
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

4.4   Special warnings and special precautions for use

None known has been deleted and replaced with Cetostearyl alcohol may cause local skin reactions (e.g.contact dermatitis).
Updated on 06/01/2006 and displayed until 31/01/2008
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 24/08/2005 and displayed until 06/01/2006
Reasons for adding or updating:
  • Addition of Legal Category
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 14/01/2002 and displayed until 24/08/2005
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 10 (date of (partial) revision of the text
Updated on 26/11/2001 and displayed until 14/01/2002
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
  • Change to section 2 - qualitative and quantitative composition
Updated on 14/08/2001 and displayed until 26/11/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 20/10/2000 and displayed until 14/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 26/05/2000 and displayed until 20/10/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 28/01/2000 and displayed until 26/05/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 28/01/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  dimeticone
  benzalkonium chloride